A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

Combining enzalutamide with standard hormone therapy cut the risk of prostate cancer death by over 40% in a clinical trial.

FRIDAY, Oct. 10, 2025 (HealthDay News) — A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

SAN FRANCISCO -- Men with advanced prostate cancer and limited metastatic recurrence lived more than twice as long without disease progression when they received metastasis-directed radioactive ...

Discover the all-new 2024 Mercedes E-Class, showcasing its advanced digital cockpit, luxury design, and the latest driver-assist features. This in-depth review highlights the sedan’s refined comfort, ...

A new study from the American Cancer Society (ACS) reports that men diagnosed with non-metastatic prostate cancer who adopted the ACS Nutrition and Physical Activity Guideline for Cancer Survivors ...

SAN FRANCISCO -- Prophylactic whole-pelvic radiation therapy (RT) did not perform as expected for patients with unfavorable intermediate-risk or favorable high-risk prostate cancer, according to ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Max Eddy Max Eddy is a writer who has covered privacy and security — including ...